Depression is common in primary care settings, but barriers prevent many primary care patients from initiating treatment. Smartphone apps stand as a possible means to overcome such barriers. However, there is limited evidence to understand the use and efficacy of these apps. The purpose of the current study was to pilot an evaluation of the usage and efficacy of apps for depression based upon behavioral or cognitive intervention skills, compared to a wait-list control. Thirty adults with depression were randomized to the use of either a behavioral app (Boost Me) or a cognitive app (Thought Challenger) or to a wait-list control. Boost Me and Thought Challenger participants received 6 weeks of the respective intervention along with weekly coaching sessions, with a 4-week follow-up period; wait-list control participants received no interventions for 10 weeks. A repeated-measures analysis of variance was conducted to examine depression over time and across treatment groups; t tests compared app usage across groups. Depression scores changed significantly over time (p Ͻ .001), with group differences occurring between Thought Challenger and wait-list control participants (p ϭ .03). Boost Me was used significantly more than was Thought Challenger (p ϭ .02); however, there was no evidence to suggest correlations between usage and changes in depression (ps Ͼ .05). The present study provides initial support that intervention strategies for depression delivered via apps with human support can impact symptoms and may promote continued use over 6 weeks. This pilot also demonstrates the feasibility of future research regarding the delivery of behavioral and cognitive intervention strategies via apps.
Patients with depression are most commonly treated in primary care settings (Linde et al., 2015) . However, most primary care patients referred for therapy do not actually initiate treatment (Mohr et al., 2006) . Indeed, multiple barriers to initiating or maintaining face-to-face interventions prevent many with depression from receiving care (González et al., 2010) . Therefore, alternative delivery mechanisms are increasingly being explored as a means to deliver care to patients with depression.
Smartphone apps are being developed and deployed as an avenue for delivering psychological interventions to those with depression (Shen et al., 2015) . Apps show promise as a delivery mechanism for a number of reasons. Their presence within a mobile device ensures that users tend to have access throughout the day. This accessibility provides opportunities for real-time monitoring, assessment, and interventions in the real-world conditions of an individual with depression (Proudfoot, 2013) . Additionally, about three quarters of all Americans own a smartphone (Smith, 2017) , increasing the possible reach of interventions delivered via apps. This reach also extends to groups that are more likely to experience stigma-related or practical barriers to tradi-tional treatment delivery (e.g., minorities and low-income users; González et al., 2010) . Apps for depression therefore have the potential to increase the accessibility and reach of psychological interventions for primary care patients with depression.
The majority of currently available apps for depression that provide an intervention (as opposed to solely monitoring or providing psychoeducation) are informed by behavioral and cognitive intervention strategies (Shen et al., 2015) . Behavioral and cognitive interventions carry the strongest body of evidence in the face-to-face administration of treatments for depression (Cuijpers et al., 2013) and are generally believed to have equivalent efficacy when delivered face-to-face (Richards et al., 2016) . However, this efficacy cannot be assumed to remain consistent when delivered through the new medium of apps.
Complicating the unknown efficacy of behavioral and cognitive interventions when delivered via apps is typically low app use. Even when prescribed by a health care provider, mental health apps have the lowest sustained rate of use after 30 days, compared to any other health and wellness apps (IMS Institute for Healthcare Informatics, 2015) . Further, the modal use of apps in a publicly available group of behavioral and cognitive intervention apps was one use (Lattie et al., 2016) . However, the relationship between use and symptom outcome has not been fully defined (Donker et al., 2013) . Evaluating the use of apps for depression may provide insights into subsequent outcomes for this delivery mechanism.
The aim of the current study was to evaluate the feasibility of a larger trial of apps for depression. Specifically, the current study pilots (a) recruitment procedures, (b) assessment procedures, (c) app usage, (d) coaching, and (e) efficacy evaluation.
Method

Participants
Recruitment of participants occurred from September 2015 to January 2016 from online ads posted on Craigslist in major American cities. Craigslist was used as the only online recruitment platform, because it (a) is free, (b) reaches major American cities, and (c) ensures that recruitment reflects the growing number of people who seek help through the Internet. Participants were eligible if they (a) had a minimum score of 10 on the Patient Health QuestionnaireϪ9 (PHQ-9; Kroenke & Spitzer, 2002) , a widely held cutoff utilized in primary care settings; (b) had a minimum score of 11 on the Quick Inventory of Depressive Symptomatology (QIDS; Rush et al., 2003) , the cutoff for moderate depression; (c) were able to speak and read English; (d) were at least 18 years old; (e) owned an Android phone (because Androids constitute the largest percentage of the market); (f) had no visual, hearing, voice, or motor impairment; (g) were not diagnosed with a comorbid diagnosis for which participation in this trial was either inappropriate or dangerous (e.g., psychotic, bipolar, or dissociative disorders; substance dependence); (h) were not severely suicidal (i.e., ideation, plan, and intent); (i) were not receiving psychotherapy; and (j) either were on a stable dose of an antidepressant medication (i.e., no dose changes for 4 weeks and did not intend to change the dose) or were not currently on antidepressant medication.
In compliance with Institutional Review Board approval, those found eligible following screening (i.e., an online survey assessing whether potential participants were over 17 years old; owned an Android phone; and did not have a diagnosis of exclusion, such as bipolar disorder) were invited to participate in a baseline eligibility phone assessment. Prior to the phone interview, participants were e-mailed a link to the detailed digital version of the study consent form. Subjects agreed to participate in the study by checking a yes box and typing in their name. After the study consent form was signed online, and before the phone assessment was completed, detailed information regarding the consent was reviewed with the participant by study staff.
Treatments
Randomization was created using PROC PLAN in SAS Version 9.2, with participants randomly assigned in randomization blocks of six to either Boost Me (n ϭ 10) or Thought Challenger (n ϭ 10) or to wait-list control (n ϭ 10). The randomized block design was used to ensure equal numbers were randomized to each group at a given time, should the study end early or if there were seasonal effects. Once generated, this list was uploaded to Research Electronic Data Capture (REDCap), where study personnel were blinded to allocation prior to randomization, and participants would be randomized once eligibility was determined. The apps were developed by the Center for Behavioral Intervention Technologies (Lattie et al., 2016) and, unlike other apps on the market, were selected for being free of cost and complying with empirically supported behavioral and cognitive intervention strategies. Boost Me and Thought Challenger participants received 6 weeks of weekly coaching sessions, didactic content delivery (one lesson per week), and use of the app (e-mailed to participants via an attachment they downloaded directly to their phones). The wait-list control group did not receive any intervention until the passage of 10 weeks occurred, to account for both the intervention period (6 weeks) and follow-up period (4 weeks). Following their completion of the final assessment, wait-list control participants were given access to both apps.
Boost Me. Boost Me is an Android app based upon activity scheduling, a core strategy of behavioral activation, which aims to increase rewarding activities and monitoring of mood in relation to behavior (J. S. Beck, 2011) . Boost Me included a persistent notification (i.e., a small box in the Android notification tray that would remain visible throughout the day) to prompt users to reflect whether they "Need a Boost?" Boost Me is currently publicly available without cost.
Thought Challenger. Thought Challenger is an Android app based upon thought restructuring, the core strategy in cognitive therapy (CT) that involves identifying and appraising maladaptive thoughts and creating adaptive counterthoughts (J. S. Beck, 2011) . Thought Challenger has demonstrated efficacy in improving CT knowledge and skills following initial use, as established through previous usability testing ( Stiles-Shields et al., 2017) . Unlike Boost Me, Thought Challenger was not designed to have a persistent notification in the Android notification tray. Thought Challenger is currently publicly available without cost.
Coaching
Participants randomized to Boost Me or Thought Challenger received weekly coaching via phone or e-mail. E-mail was utilized This document is copyrighted by the American Psychological Association or one of its allied publishers.
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as a means of contact if (a) the participant was unable to be reached via phone or (b) the participant requested e-mail contact for a given week. Coaching was based on the supportive accountability model, which proposes that coaches increase adherence to apps by providing accountability in the context of a supportive relationship (Mohr, Cuijpers, & Lehman, 2011) . The first coaching call involved asking the participant to open the app during the call to discuss the app features. All coaching calls were brief (i.e., typically 5 min or less) and were aimed at maintaining engagement with the app and not in providing therapeutic intervention (e.g., "How could you use the app this week to help your mood?" "What would be a good goal for using the app this week?"). The same master's-level licensed clinician provided coaching to all participants in the trial.
Assessment
The baseline assessment interview was conducted via telephone. To maximize blinding, we administered only self-report measures beyond the baseline assessment. Self-report assessments occurred at baseline, at Weeks 3 and 6 (midtreatment and end of treatment), and at Week 10 (1 month posttreatment follow-up) via REDCap, electronic data capture tools hosted at the university (Harris et al., 2009 ). Assessments were spaced in this way to minimize possible assessment burden for participants. Participants were compensated $15 and $10 for the baseline and follow-up assessments, respectively.
Measures of psychological characteristics. The PHQ-9, completed at all time points, is a self-report instrument measuring depressive symptomology (Kroenke & Spitzer, 2002) . The PHQ-9 was selected as the primary outcome measure due to its frequent use in primary care to screen for and monitor depression, enhancing generalizability to primary care settings.
The QIDS is a 16-item interview intended to evaluate objective, evaluator-rated symptom severity (Rush et al., 2003) . The Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1997 ) is a structured diagnostic interview to diagnose psychiatric disorders according to the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders and the International Statistical Classification of Diseases and Related Health Problems. The QIDS and MINI were administered at baseline to assess whether the depressive symptoms had been present for at least 2 weeks and to determine eligibility based upon possible comorbid conditions that would make participation in the trial inappropriate, respectively.
Measure of usability. The System Usability Scale (SUS) is a self-report instrument measuring a user's rating of a product's usability (Brooke, 1996) and was administered at Weeks 3 and 6 for the Boost Me and Thought Challenger participants.
Safety Protocol
To ensure participants' safety, anyone rating higher than 1 (Several Days) on Item 9 ("Thoughts that you would be better off dead, or of hurting yourself") of the PHQ-9 (Kroenke & Spitzer, 2002) was prompted to also answer Item 9 ("Suicidal Thoughts or Wishes") of the Beck Depression Inventory (BDI; A. T. Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) . Participants then received a notification that the response would be reviewed within one business day and that they should go to the nearest emergency department or call 911 in the case of an emergency. If a participant rated a 2 or higher on the BDI item, study staff were notified by REDCap to trigger an administration of the Columbia-Suicide Risk Assessment (Posner et al., 2011) via telephone. Any participants with severe suicidality (i.e., ideation, plan, and intent) were excluded.
Data Analysis
Baseline demographic variables were compared across treatment arms using one-way analysis of variance (ANOVA) and chi-square tests of association. A repeated-measures ANOVA was conducted to examine depressive symptoms over time and across treatment groups. Participants with missing data were eliminated casewise. To compare usage and perceptions of usability across apps, t tests were conducted. Any participants without usage (e.g., launch of the app) or engagement with the coach were included in the analyses, because that is a representation of their total usage of these services. To examine the relationship between usage and change in depressive symptoms, we ran bivariate correlations between the usage variables and change in depression between baseline and end of treatment. Bivariate correlations were run among the number of coaching sessions and duration of calls, usage variables, and change in depression between baseline and end of treatment (Week 6). All analyses were run in IBM SPSS Statistics (Version 23), at the nominal .05 Type I error rate. Post hoc tests were run using a Bonferroni correction to prevent inflation of the overall Type I error rate.
Results
Participants
The flow of participants through this study is displayed in Figure 1 . There were no significant differences in demographics across treatment groups at baseline. All Boost Me participants received the intervention. Three Thought Challenger participants did not receive the intervention; one reported not having enough device memory to download the app, and two were unresponsive to contact following randomization. There were no adverse events (e.g., severe suicidality). Baseline PHQ-9 scores were significantly higher than any other time point (ps Ͻ .001). Midtreatment (Week 3) and end-of-treatment (Week 6) PHQ-9 scores demonstrated a decrease in severity over time, with significant differences emerging between these time points (p ϭ .02). Follow-up (Week 10) PHQ-9 scores showed an increase in symptoms, with no evidence to suggest differences between scores at follow-up, compared to midtreatment and end of treatment (ps Ͼ .9). This document is copyrighted by the American Psychological Association or one of its allied publishers.
Depression Scores
Group. Post hoc analyses with a Bonferroni correction indicated significant differences in PHQ-9 scores over time between Thought Challenger and wait-list control participants (p ϭ .03). There was no evidence to suggest differences in PHQ-9 scores among Boost Me participants and the other two groups (ps Ͼ .2).
Usage
Boost Me was launched significantly more than was Thought Challenger (97.7 vs. 33.5), t(18) ϭ 2.59, p ϭ .02, d ϭ 1.16. No significant differences emerged in the number of events (Boost Me: 14.7 Ϯ 10.1) and thoughts (Thought Challenger: 8.5 Ϯ 11.6) logged overall (p ϭ .22, d ϭ .57) or in event (7.5 Ϯ 7.3) or thought (5.4 Ϯ 4.5) reviews (p ϭ .45, d ϭ .35).
App usage was not significantly correlated with changes in depression scores, either within the entire sample (i.e., Boost Me and Thought Challenger totals) or by group (e.g., only Boost Me totals; ps Ͼ .05).
Usability
Midtreatment (Week 3) mean SUS scores indicated that Thought Challenger (84.10 Ϯ 10.43) was rated significantly higher than was Boost Me (70.00 Ϯ 14.31), t(15) ϭ Ϫ2.29, p ϭ .04, d ϭ 1.12. However, at the end of treatment (Week 6), there was no significant difference in mean SUS scores between Thought Challenger (88.57 Ϯ 5.56) and Boost Me (78.33 Ϯ 15.10), t(14) ϭ Ϫ1.70, p ϭ .11, d ϭ .90. Note. Scores presented for the Patient Health Questionnaire-9 (PHQ-9; primary outcome measure). Data are means, with standard deviations in parentheses. Mid ϭ midtreatment; EOT ϭ end of treatment; FU ϭ follow-up. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Coaching
Use of phone and e-mail contact did not significantly differ between Boost Me and Thought Challenger participants, except in Week 5, in which Boost Me had a higher percentage of phone contact (70.0% vs. 11.1%), 2 (1, N ϭ 19) ϭ 6.74, p ϭ .009, ϭ .60. There was no evidence to suggest a difference in the number or duration of coaching calls (Boost Me ϭ 6.20 Ϯ 3.30 min; Thought Challenger ϭ 4.27 Ϯ .83 min), and the length and number of coaching calls were not significantly correlated with app usage (ps Ͼ .05).
Discussion
The present study piloted an evaluation of the employment of apps as delivery mechanisms for behavioral and cognitive intervention skills. The study supported the feasibility of conducting a randomized controlled trial evaluating mobile apps for depression, including online recruitment, retention, and engagement with apps and coaching. Thought Challenger showed a significantly greater impact on depressive symptoms, whereas Boost Me produced significantly greater usage. Of note, depressive scores increased during follow-up, but these differences were not significant. These findings should be interpreted cautiously, however, given the small sample size, which can increase the likelihood of spurious outcome findings.
The high usage of Boost Me, with an average of nearly 100 app launches over 6 weeks, stands in contrast to much lower usage patterns of Thought Challenger and open access apps without human support (Lattie et al., 2016) . There are multiple possible explanations for this amount of use that may be considered to promote usage in similar apps. First, users are encouraged to use the app twice: (a) to schedule the activity and (b) to rate how the activity actually impacted their mood. This promotion of two uses is in contrast to Thought Challenger's single use when restructuring a thought. However, although this design may explain some increase in use, actual use indicates that about half of the planned boosts resulted in only one use of the app. Second, Boost Me had a persistent notification, which may have prompted increased use. Last, Boost Me was designed to promote positive behaviors, with the aim of providing an immediate improvement in mood. These behaviors include self-generated and auto-generated suggestions. In contrast to the design of Thought Challenger, that of Boost Me may promote reliance upon the app to select rewarding behaviors to engage in when in a lowered mood state, promoting frequent and ongoing use of the app. There are multiple aspects of the design of Boost Me that may have influenced higher usage patterns than for Thought Challenger or similar publicly available intervention apps.
Limitations of the current work should be considered in the interpretation of these findings. First, as a pilot trial, the sample size was small. Small samples are typically underpowered to identify significant effects and can also introduce potential sampling biases. However, the effect sizes associated with the findings were generally medium to large. Attrition was also low (Յ10% at all time points), demonstrating the feasibility of executing a larger trial evaluating apps for depression. However, all the missing data occurred in one treatment arm, Thought Challenger. Second, the same person performed the roles of investigator, assessor, and coach, increasing the likelihood of investigator bias impacting the evaluation of clinical symptoms. Although all follow-up assessment time points were conducted via self-report questionnaires to limit investigator bias, these findings were not cross-validated through objective assessment. Third, Craigslist was the sole recruitment method, necessitating 120 participant screens over 4 months' time to achieve the sample size of 30. It is likely that other methodologies may be more effective in timely recruitment for mental health app research. Finally, it should be emphasized that these were coached interventions; the findings likely would not generalize to use without human support. Although coaching may be expected in deployment through health care settings, it would be unusual for public deployment through app stores.
The findings of the present study indicate that intervention strategies for depression delivered via apps may impact symptomology and promote continued use over 6 weeks. The current study demonstrates the feasibility of future research regarding the delivery of intervention strategies via apps and how this delivery mechanism may overcome barriers to care for primary care patients with depression.
